Retinopathy Of Prematurity - Pipeline Review, H2 2016

Publisher Name :
Date: 14-Sep-2016
No. of pages: 36
Inquire Before Buying

Global Markets Direct's, ‘Retinopathy Of Prematurity - Pipeline Review, H2 2016', provides an overview of the Retinopathy Of Prematurity pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Retinopathy Of Prematurity, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Retinopathy Of Prematurity and features dormant and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

  • The report provides a snapshot of the global therapeutic landscape of Retinopathy Of Prematurity

  • The report reviews pipeline therapeutics for Retinopathy Of Prematurity by companies and universities/research institutes based on information derived from company and industry-specific sources

  • The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages

  • The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities

  • The report reviews key players involved Retinopathy Of Prematurity therapeutics and enlists all their major and minor projects

  • The report assesses Retinopathy Of Prematurity therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type

  • The report summarizes all the dormant and discontinued pipeline projects

  • The report reviews latest news related to pipeline therapeutics for Retinopathy Of Prematurity

Reasons to buy

  • Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies

  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

  • Identify and understand important and diverse types of therapeutics under development for Retinopathy Of Prematurity

  • Identify potential new clients or partners in the target demographic

  • Develop strategic initiatives by understanding the focus areas of leading companies

  • Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics

  • Devise corrective measures for pipeline projects by understanding Retinopathy Of Prematurity pipeline depth and focus of Indication therapeutics

  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

  • Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

Retinopathy Of Prematurity - Pipeline Review, H2 2016

Table of Contents

Table of Contents 2
List of Tables 4
List of Figures 4
Introduction 5
Global Markets Direct Report Coverage 5
Retinopathy Of Prematurity Overview 6
Therapeutics Development 7
Pipeline Products for Retinopathy Of Prematurity - Overview 7
Retinopathy Of Prematurity - Therapeutics under Development by Companies 8
Retinopathy Of Prematurity - Pipeline Products Glance 9
Late Stage Products 9
Early Stage Products 10
Retinopathy Of Prematurity - Products under Development by Companies 11
Retinopathy Of Prematurity - Companies Involved in Therapeutics Development 12
Biomar Microbial Technologies 12
F. Hoffmann-La Roche Ltd. 13
Retinopathy Of Prematurity - Therapeutics Assessment 14
Assessment by Monotherapy Products 14
Assessment by Target 15
Assessment by Mechanism of Action 17
Assessment by Route of Administration 19
Assessment by Molecule Type 21
Drug Profiles 23
AP-202 - Drug Profile 23
Product Description 23
Mechanism Of Action 23
R&D Progress 23
IB-09A0133 - Drug Profile 24
Product Description 24
Mechanism Of Action 24
R&D Progress 24
R-200 - Drug Profile 25
Product Description 25
Mechanism Of Action 25
R&D Progress 25
ranibizumab - Drug Profile 26
Product Description 26
Mechanism Of Action 26
R&D Progress 26
Recombinant Protein for Cancer and Diabetic Retinopathy - Drug Profile 32
Product Description 32
Mechanism Of Action 32
R&D Progress 32
Retinopathy Of Prematurity - Dormant Projects 33
Retinopathy Of Prematurity - Discontinued Products 34
Appendix 35
Methodology 35
Coverage 35
Secondary Research 35
Primary Research 35
Expert Panel Validation 35
Contact Us 35
Disclaimer 36

List of Tables

Number of Products under Development for Retinopathy Of Prematurity, H2 2016 7
Number of Products under Development by Companies, H2 2016 8
Comparative Analysis by Late Stage Development, H2 2016 9
Comparative Analysis by Early Stage Development, H2 2016 10
Products under Development by Companies, H2 2016 11
Retinopathy Of Prematurity - Pipeline by Biomar Microbial Technologies, H2 2016 12
Retinopathy Of Prematurity - Pipeline by F. Hoffmann-La Roche Ltd., H2 2016 13
Assessment by Monotherapy Products, H2 2016 14
Number of Products by Stage and Target, H2 2016 16
Number of Products by Stage and Mechanism of Action, H2 2016 18
Number of Products by Stage and Route of Administration, H2 2016 20
Number of Products by Stage and Molecule Type, H2 2016 22
Retinopathy Of Prematurity - Dormant Projects, H2 2016 33
Retinopathy Of Prematurity - Discontinued Products, H2 2016 34

List of Figures

Number of Products under Development for Retinopathy Of Prematurity, H2 2016 7
Number of Products under Development by Companies, H2 2016 8
Comparative Analysis by Early Stage Products, H2 2016 10
Assessment by Monotherapy Products, H2 2016 14
Number of Products by Targets, H2 2016 15
Number of Products by Stage and Targets, H2 2016 15
Number of Products by Mechanism of Actions, H2 2016 17
Number of Products by Stage and Mechanism of Actions, H2 2016 17
Number of Products by Routes of Administration, H2 2016 19
Number of Products by Stage and Routes of Administration, H2 2016 19
Number of Products by Molecule Types, H2 2016 21
Number of Products by Stage and Molecule Types, H2 2016 21
  • Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) Ophthalmology Amniotic Membrane Market 2017 Forecast to 2022
    Published: 14-Nov-2017        Price: US 4880 Onwards        Pages: 116
    Amniotic membrane (AM) can function in the eye as a basement membrane substitute or as a temporary graft. It has anti-inflammatory and anti-scarring effects and contains growth factors that promote epithelial wound healing on the surface of the eye. Scope of the Report: This report focuses on the Ophthalmology Amniotic Membrane in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market ba......
  • Global Ophthalmology Amniotic Membrane Market Professional Survey Report 2017
    Published: 13-Nov-2017        Price: US 3500 Onwards        Pages: 109
    This report studies Ophthalmology Amniotic Membrane in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering - Derma Sciences - FzioMed - Alliqua BioMedical - Skye......
  • United States Artificial Tears Market by Manufacturers, States, Type and Application, Forecast to 2022
    Published: 07-Nov-2017        Price: US 4480 Onwards        Pages: 122
    This report studies the Artificial Tears market, Artificial Tears are lubricant eye drops used to treat the dryness and irritation associated with deficient tear production in keratoconjunctivitis sicca (dry eyes). They are also used to moisten contact lenses and in eye examinations. Scope of the Report: This report focuses on the Artificial Tears in United States market, to split the market based on manufacturers, states, type and application. Market Segment......
  • United States Conjunctivitis Market Report 2017
    Published: 06-Nov-2017        Price: US 3800 Onwards        Pages: 110
    In this report, the United States Conjunctivitis market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report splits the United States market into seven regions: - The West - Southwest - The Middle Atlantic - New England - The South - The Midwest with sales (volume), revenue (value), market share and growth rate of C......
  • Global Ophthalmic Suspension Market Professional Survey Report 2017
    Published: 03-Nov-2017        Price: US 3500 Onwards        Pages: 102
    This report studies Ophthalmic Suspension in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering - Novartis AG - ALLERGAN - Pfizer - Merck - Bausch & Lomb......
  • Global Sustained Release Ocular Drug Delivery Systems Market Research Report 2017
    Published: 02-Nov-2017        Price: US 2900 Onwards        Pages: 110
    In this report, the global Sustained Release Ocular Drug Delivery Systems market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Sustained Release Ocular Drug Delivery Systems in these regions, from 2012 to 2022 (forecast), covering......
  • Global Ophthalmics Partnering 2010-2017: Deal trends, players and financials
    Published: 01-Nov-2017        Price: US 2995 Onwards        Pages: 500
    "Delivery of this report will take 1-3 days after purchase." Global Ophthalmics Partnering 2010 to 2017 provides the full collection of Ophthalmics disease deals signed between the world's pharmaceutical and biotechnology companies since 2010. Trends in Ophthalmics partnering deals Financial deal terms for headline, upfront and royalty by stage of development Ophthalmics partnering agreement structure Ophthalmics partnering cont......
  • Diabetic Retinopathy - Market Insights, Epidemiology and Market Forecast-2023
    Published: 01-Nov-2017        Price: US 4950 Onwards        Pages: 88
    DelveInsight's Diabetic Retinopathy - Market Insights, Epidemiology and Market Forecast-2023 Report provides an overview of the epidemiology trends of Diabetic Retinopathy in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epidemiology historical and forecasted data of Diabetic Retinopathy prevalent or incident cases segmented by age, sex and subpopulations. The Report also discusses the prevailing risk factors, disease burden with special emphasis on ......
  • Uveal Melanoma - Market Insights, Epidemiology and Market Forecast - 2025
    Published: 01-Nov-2017        Price: US 5750 Onwards        Pages: 70
    DelveInsight's "Uveal Melanoma - Market Insights, Epidemiology and Market Forecast - 2025" report provides an overview of the disease and in depth research related to Uveal Melanoma for the 7MM (United States, Germany, France, Italy, Spain and UK) for the study period undertaken from 2015-2025. This report provides understanding of the patients affected, diagnosed patterns, treatment trends, unmet medical needs and current developments for Uveal Melanoma . It enables understanding of the histori......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs